Kaye Randall — SEC Form 4 filings
SEC reporting owner CIK 1350416. 7 Form 4 filings on record with FilingPulse; latest filed 2024-12-02.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-02-09 to 2024-12-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 100 shares, $2,482 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 8 legs across 3 filings — 50,100 shares, $2,092,146 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: sale of 16,667 shares @ $59.03 ($983,936) in Longboard Pharmaceuticals, Inc., filed 2024-10-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Longboard Pharmaceuticals, Inc. (LBPH) | Executive Vice President & CMO | 7 | 1 leg · 100 sh · $2,482 | 8 legs · 50,100 sh · $2,092,146 | 17 |
Form 4 filings — Kaye Randall
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2024-12-02 | 4 | Longboard Pharmaceuticals, Inc. (LBPH) | Code (U): 30,554 @ $60 · Disposition to issuer (D): 175,946 (derivative) · Disposition to issuer (D): 96,300 (derivative) · Disposition to issuer (D): 107,560 (derivative) · Disposition to issuer (D): 17,920 (derivative) · Disposition to issuer (D): 9,500 (derivative) | EDGAR |
| 2024-11-19 | 4 | Longboard Pharmaceuticals, Inc. (LBPH) | Option exercise (M): 30,554 @ $6 · Option exercise (M): 30,554 (derivative) @ $0 | EDGAR |
| 2024-10-29 | 4 | Longboard Pharmaceuticals, Inc. (LBPH) | Grant/award (A): 9,500 (derivative) @ $0 | EDGAR |
| 2024-10-16 | 4 | Longboard Pharmaceuticals, Inc. (LBPH) | Option exercise (M): 16,667 @ $4.35 · Sale (S): 16,667 @ $59.03 · Option exercise (M): 16,667 (derivative) @ $0 | EDGAR |
| 2024-09-16 | 4 | Longboard Pharmaceuticals, Inc. (LBPH) | Option exercise (M): 16,666 @ $4.35 · Sale (S): 9,366 @ $30.89 · Sale (S): 4,200 @ $31.81 · Sale (S): 1,200 @ $33.12 · Sale (S): 1,900 @ $34.04 · Option exercise (M): 16,666 (derivative) @ $0 | EDGAR |
| 2024-08-13 | 4 | Longboard Pharmaceuticals, Inc. (LBPH) | Purchase (P): 100 @ $24.82 · Sale (S): 100 @ $20.87 · Option exercise (M): 16,667 @ $4.35 · Sale (S): 10,476 @ $34.55 · Sale (S): 6,191 @ $35.03 · Option exercise (M): 16,667 (derivative) @ $0 | EDGAR |
| 2024-02-09 | 4 | Longboard Pharmaceuticals, Inc. (LBPH) | Grant/award (A): 17,920 @ $0 · Grant/award (A): 107,560 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1350416 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →